Mymetics Corporation – OTC:MYMX

Mymetics stock price today

$0.026
+0.02
+2542.5%
Financial Health
0
1
2
3
4
5
6
7
8
9

Mymetics key metrics

Market Cap
 7.89M
Enterprise value
 77.07M
P/E
 -0.67
EV/Sales
 25693.05
EV/EBITDA
 -32.46
Price/Sales
 1721.29
Price/Book
 -0.08
PEG ratio
 N/A
EPS
 -0.03
Revenue
 359.65K
EBITDA
 -2.45M
Income
 -11.06M
Revenue Q/Q
 -71.54%
Revenue Y/Y
 -16.35%
Profit margin
 -170900%
Oper. margin
 -56766.67%
Gross margin
 -39600%
EBIT margin
 -56766.67%
EBITDA margin
 -682.88%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Mymetics stock price history

Mymetics stock forecast

Mymetics financial statements

Profit Margin

Mymetics Corporation (OTC:MYMX): Profit margin
Dec 2022 118.32K -1.32M -1121.48%
Mar 2023 3K -942K -31400%
Jun 2023 201.34K -7.68M -3816.87%
Sep 2023 36.98K -1.11M -3011.95%
MYMX income statement history

Debt to Assets

Mymetics Corporation (OTC:MYMX): Debt to assets
Dec 2022 7321000 72.21M 986.44%
Mar 2023 7324000 74.08M 1011.48%
Jun 2023 533000 74.98M 14068.29%
Sep 2023 100000 75.67M 75670%
MYMX balance sheet history

Cash Flow

Mymetics Corporation (OTC:MYMX): Cash Flow
Dec 2022 -321K 34 236K
Mar 2023 -478K 0 500K
Jun 2023 -604K 92K 588K
Sep 2023 -335K 2K -2K
MYMX cash flow history

Mymetics alternative data

Mymetics
Employees

Mymetics Corporation (OTC:MYMX): Employee count
Aug 2023 11
Sep 2023 2
Oct 2023 2
Nov 2023 2
Dec 2023 2
Jan 2024 2
Feb 2024 2
Mar 2024 2
Apr 2024 2
May 2024 2
Jun 2024 2
Jul 2024 2

Mymetics other data

Mymetics
Insider Trading

Mymetics Corporation (OTC:MYMX): Insider trades (number of shares)
Period Buy Sel
Jul 2010 0 150000
Transaction Date Insider Security Shares Price per share Total value Source
Option
KEMPERS RONALD HUGO GERARD officer: Presiden.. Common Stock 3,000,000 $0.02 $60,000
Sale
MARTIN JACQUES FRANCOIS officer: CEO
 Common Stock 150,000 $0.2 $30,000
Sale
ROCHET CHRISTIAN director
 Common Stock 1,917,276 $0.17 $333,606
Purchase
ROCHET CHRISTIAN director, officer: CEO, President
 Common Stock 6,000,000 N/A N/A
MYMX insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Mymetics stock today?

    One share of Mymetics stock can currently be purchased for approximately $0.03.

  • When is Mymetics's next earnings date?

    Unfortunately, Mymetics's (MYMX) next earnings date is currently unknown.

  • Does Mymetics pay dividends?

    No, Mymetics does not pay dividends.

  • How much money does Mymetics make?

    Mymetics has a market capitalization of 7.89M.

  • What is Mymetics's stock symbol?

    Mymetics Corporation is traded on the OTC under the ticker symbol "MYMX".

  • What is Mymetics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Mymetics?

    Shares of Mymetics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Mymetics's key executives?

    Mymetics's management team includes the following people:

    • Dr. Sylvain Fleury Chief Scientific Officer(age: 63, pay: $318,720)
    • Mr. Ronald Kempers Chief Executive Officer, Pres & Chief Financial Officer(age: 57, pay: $318,720)

  • How many employees does Mymetics have?

    As Jul 2024, Mymetics employs 2 workers.

  • When Mymetics went public?

    Mymetics Corporation is publicly traded company for more then 25 years since IPO on 3 Apr 2000.

  • What is Mymetics's official website?

    The official website for Mymetics is mymetics.com.

  • How can i contact Mymetics?

    Mymetics can be reached via phone at +41 21 653 45 35.

Mymetics company profile:

Mymetics Corporation

mymetics.com
Exchange:

OTC

Full time employees:

9

Industry:

Biotechnology

Sector:

Healthcare

Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

+41 21 653 45 35
BiopOle Center
Epalinges, 1066

CIK: 0000927761
ISIN: US62856A1025
CUSIP: 62856A102